(19659001) HONG KONG July 9, 2025 (ACN Newswire), Cornerstone Robotics has announced the official clinical investigation of their Hong Kong developed surgical robotic system, at Portsmouth Hospitals University NHS Trust, Portsmouth, UK. The Sentire(r), Endoscopic Surgical System C1000, developed by Hong Kong’s Cornerstone Robotics Limited is being evaluated at PHU Queen Alexandra Hospital, Portsmouth, UK. This groundbreaking initiative marks the first clinical deployment in the UK and Europe of the Sentire(r) System, a major milestone for international clinical collaboration. It also marks the beginning of Cornerstone’s commercial activities in the area. PHU’s surgical group, led by Professor Jim Khan and using the Sentire(r), successfully performed three colorectal operations to kick off the clinical trial.
The clinical investigation is focused on assessing the safety and efficacy of the Sentire(r) system for performing colorectal and urological procedures within European populations–expanding upon previous clinical data generated in Asia. The trial is based on international standards of device evaluation and marks a significant regulatory milestone for a Chinese robot platform.
I was impressed by how quickly my team adapted to Sentire(r), Surgical System, said Jim KhanChief Investigator. The platform worked smoothly and reliably. I would like to thank the Cornerstone Robotics team for their outstanding assistance throughout this pioneering stage.
Prof Samuel Au, CEO at Cornerstone Robotics commented: “This moment is a proud one for our company as well as for the broader innovation eco-system in Hong Kong.” We are proud to partner with PHU and launch this CSR’s very first investigation in the UK. We believe that the results will help validate the capabilities of Sentire(r), Endoscopic Surgical System, and deliver greater accessibility and efficiency to surgical robotics in UK, EU and beyond.”
Sentire(r), Endoscopic Surgical System combines integrated engineering, software and imaging technologies in order to support surgeons performing intricate minimally invasive surgeries. Early clinical feedback suggests these features could contribute to streamlined surgical workflows and improved outcomes for the patients.
The collaboration strengthens PHU’s leadership in surgical robotics. PHU was the first UK hospital to offer a robotic-assisted surgery day program. It has performed more than 5,000 robotic procedures in colorectal, upper gastrointestinal and gynaecological specialty areas. This is a model that can be used by the NHS for the adoption of advanced surgical technologies.
Portsmouth Hospitals University NHS Trust.
Portsmouth Hospitals University NHS Trust. (PHU), provides acute hospital services for over 675,000 Hampshire residents. PHU, based at Queen Alexandra Hospital in London, is an international leader when it comes to surgical robotics. It has pioneered minimally-invasive surgery since the early 2000s. PHU is one of the first adopters of robotics, having completed more than 5,000 procedures in multiple specialties. This has helped redefine surgical care within the NHS. PHU is also a leader in clinical robotics, having adopted the UK’s very first robotic-assisted surgery programme.
About Cornerstone Robotics Limited
Cornerstone Robotics is a leading medical innovator that advances surgical care by using cutting-edge robotic systems. This makes high-quality healthcare accessible and efficient to everyone worldwide. CSR was founded in 2019. It has a global team of surgeons, clinical professionals and multidisciplinary innovators. This team is driving rapid growth in key hubs such as Hong Kong, Shenzhen (China), Beijing, Shanghai (USA), Amsterdam (NL) and a R&D collaboration center in Portsmouth (UK). We are pioneering robotic solutions in soft tissue and other surgical fields. See https://en.csrbtx.com.
Contact :
Cornerstone Robotics Limited.
Email support@csrbtx.com.
Topic : Corporate Announcement.
Sectors : Healthcare & Pharm., MedTech.
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright (c) 2025 ACN Newswire. All rights reserved. All rights reserved.
